The purpose of this study is to examine the feasibility and acceptability of a drug called paricalcitol in adults with chronic pancreatitis (CP). The study aims to discover factors that are associated with improved symptoms when receiving paricalcitol. Findings will provide information needed to conduct larger (future) studies that evaluate the benefit of paricalcitol treatment to a portion of the CP populations likely to respond to therapy. Participants will be randomly assigned to receive either paricalcitol or placebo (inactive substance) and will complete questionnaires, in addition to other study procedures. Researchers hope that paricalcitol will have positive effects in patients with CP in reducing chronic pain associated with the disease, as well as overall quality of life and improved outcomes. The use of paricalcitol in this study is investigational.
What is the full name of this clinical trial?
A Pilot Clinical Trial of Paricalcitol for Chronic Pancreatitis